Presence of diabetes related complication at the time of NIDDM diagnosis: An important prognostic factor

European Journal of Epidemiology

Volumn 14, Issue 5, 1998, Pages 439-445

  Ruigomez A ^a   Garcia Rodriguez L A ^a  

^a Department of Pharmacoepidemiology   (Spain)

Author keywords

Automated database; Cohort study; Mortality; NIDDM complications; Risk factors

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DATA BASE; DISEASE COURSE; EYE DISEASE; FEMALE; GENERAL PRACTICE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031874427     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007484920656     Document Type: Article

References (31)

1. Harris MI, Eastman RC. Early detection of undiagnosed non-insulin dependent diabetes mellitus. JAMA 1996; 276: 1261-1261.
2. Harris MT. Undiagnosed NIDDM: Clinical and public health issues. Diabetes Care 1993; 16: 641-652.
3. Marks L. Counting the cost: The real impact of non-insulin dependent diabetes. King's Fund Policy Institute. London: British Diabetic Association, 1996: 12-17.
4. United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. Br Med J 1995; 310: 83-88.
5. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin dependent diabetes mellitus. Ann Intern Med 1996; 124: 136-145.
6. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 13: 815-819.
7. García Rodríguez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45: 419-426.
8. Jick H, Jick SS, Derby LE, Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991; 302: 766-768.
9. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Safety 1992; 1: 347-349.
10. Van Staa J-P, Abenhaim L. The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Safety 1994, 3: 15-21.
11. UKPDS Group. UK Prospective diabetes study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990; 13: 1-11.
12. Cohen DL, Neil HAW, Thnrogood M, Mann JI. A population-based study of the incidence of complication associated with type 2 diabetes in the elderly. Diabetic Med 1991; 8: 928-933.
13. Perri IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. Br Med J 1995; 310: 560-564.
14. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy III, prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-532.
15. Dwyer MS, Melton LJ, Ballard DJ, Palumbo PJ, Trautman JC, Chu CP. Incidence of diabetic retinopathy and blindness: A population-based study in Rochester, Minnesota. Diabetes Care 1985; 8: 316-322.
16. Klein R, Klein BEK. Vision disorders in diabetes. In: Harris MI, Cowie CC, Reiber G, Stern M, Bennett P (eds), Diabetes in America, 2nd ed. Washington, DC: US Government Printing Office, 1995: 293-338.
17. Nelson RG, Knowler WC, Pettitt DJ, Bennett PH. Kidney diseases in diabetes. In: Harris MI, Cowie CC, Reiber G, Stern M, Rennett P (eds), Diabetes in America, 2nd ed. Washington, DC: US Government Printing Office, 1995: 349-376.
18. Ballard DJ, Humphrey LL, Melton III LJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ. Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 1988; 37: 405-412.
19. Humphrey LL, Ballard DJ, Frohnert PP, Chu PP, O'Fallon WM, Palumbo P. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med 1989; 111: 788-796.
20. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J, The DIS Group. Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study. 11-year follow-up. Diabctologia 1996; 39: 1577-1583.
21. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979: 2035-2038.
22. Keen H, Jarrelt RJ. The WHO multinational study of vascular disease in diabetes: 2. Macrovascular disease prevalence. Diabetes Care 1979; 2: 187-195.
23. Roscngrcn A, Wclin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: A general population study. Br Med J 1989; 299: 1127-1131.
24. Andcrsson DKG, Svärdsudd K. Long-term glycemic control related to mortality in Type II diabetes. Diabetes Care 1995; 18: 1534-1543.
25. Chaturvedi N, Jarret J, Morrish N, Keen H, Fuller JH. Differences in mortality and morbidity in African carribean and European people with non-insulin dependent diabetes mellitus: Results of 20 year follow up of a London cohort of multinational study. Br Med J 1996; 313: 848-852.
26. Walters DP, Galling W, Mulee MA, Hill RD. The prevalence of diabetic distal sensory neuropathy in an English community. Diabetic Med 1992; 9: 349-353.
27. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin dependent diabetes. In: Harris MI, Cowie CC, Reiber G, Stern M, Bennett P (eds), Diabetes in America, 2nd ed. Washington, DC: US Government Printing Office, 1995: 233-258.
28. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 123-131.
29. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 36: 1175-1184.
30. Fontbonne A, Thibault N, Eschwège E, Ducimetière P. Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: The Paris Prospective Study, 15-year follow-up. Diabetologia 1992; 35: 464-468.
31. Balkau B, Eschwege E, Papoz L, Richard J-L, Claude J-R, Warnet J-M, Ducimetière P. Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. Br Med J 1993; 307: 295-299.